Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (LLS) exists to find cures and ensure access to the best available treatments for blood cancer patients. LLS is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. LLS has chapters throughout the country and in Canada.

Latest from Leukemia & Lymphoma Society

Third Full Dose of COVID-19 Vaccine Increases Antibody Response in Patients with Blood Cancers

December 23, 2021

Article

New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.

What Patients With Blood Cancers Need to Know About COVID-19, Booster Shots and More

October 21, 2021

Podcast

An expert from the Leukemia & Lymphoma Society breaks down the effectiveness of the COVID-19 vaccine in patients with blood cancers on this episode of the “Cancer Horizons” podcast.

Bouncing Back: The Leukemia Survivor Who Became a Bone Marrow Transplant Nurse

October 21, 2021

Article

A three-time acute lymphoblastic leukemia survivor became a bone marrow transplant nurse and now helps other patients with the same diagnosis.

Third COVID-19 Vaccine Dose in Blood Cancers May Boost Antibody Production

October 13, 2021

Article

Patients with blood cancers may respond differently to doses of the COVID-19 vaccines based on the treatment they’re receiving, for example.

Join Our Community

September 16, 2021

Article

LLS Community is an online gathering place for patients, caregivers and healthcare professionals to share experiences and provide support.

New Study Shows Most Blood Cancer Patients Benefit from an Additional COVID-19 Vaccine Dose

September 15, 2021

Article

Immune suppressing treatments — an essential component of many patients' cancer care — can blunt vaccine immune response.

FDA Approves Brukinsa for Marginal Zone Lymphoma Treatment

September 15, 2021

Article

Patients with relapsed/refractory, pretreated marginal zone lymphoma are now eligible for treatment with Brukinsa.

Patients With Blood Cancer Less Likely to Produce COVID-19 Antibodies After Vaccination

July 26, 2021

Article

About 25% of patients with blood cancer did not produce antibodies after being vaccinated against COVID-19.

Why the COVID-19 Vaccine is Important for Patients with Blood Cancers

April 27, 2021

Video

Patients with blood cancers are at a much higher risk of complications if they contract COVID-19, says an expert from the Leukemia & Lymphoma Society (LLS).

Keep it Flowing: Combating COVID-19 Blood Shortages in Cancer Treatment

February 12, 2021

Article

Blood shortages during the COVID-19 pandemic have forced cancer centers to get creative to ensure patients with hematologic malignancies are able to get transfusions in a timely manner.

CURE® Speaking Out Video Series Supports Blood Cancer Awareness Month and World Lymphoma Awareness Day

September 10, 2020

Article

Susan M. O’Brien, M.D., one of the nation’s foremost leukemia experts, discusses the future of frontline therapies and upcoming clinical trials associated with chronic lymphocytic leukemia.

Joining a Chronic Lymphocytic Leukemia Trial

August 25, 2020

Video

Living with CLL as a Chronic Disease

August 25, 2020

Video

The Future of Frontline Therapy in CLL

August 25, 2020

Video

Understanding the Basics of Chronic Lymphocytic Leukemia

August 25, 2020

Video

Extended-Release Metformin Voluntarily Recalled Due to Cancer Risks, Former Senate Majority Leader Harry M. Reid is Cancer Free, and More

June 12, 2020

Article

From the American Cancer Society laying off 1,000 employees due to the economic impact of COVID-19 to former Senate Majority Leader Harry Reid announcing his cancer is in remission after receiving an experimental treatment, here’s what’s making the headlines in the cancer space this week.

How One Organization is Helping Patients with Blood Cancers Through the COVID-19 Pandemic

April 22, 2020

Video

Patients with blood cancers are facing unprecedented challenges to their treatment journeys as the COVID-19 pandemic continues to disrupt the cancer landscape. Which is why the Leukemia and Lymphoma Society is looking to offer its own lifeline to patients.

Your Questions Answered About Coronavirus (COVID-19)

April 02, 2020

Article

Two hematologist/oncologists on the LLS leadership team, and experts in the field of blood cancer, answer questions and concerns about coronavirus (COVID-19).

Speaking Out: Treatment Options May Expand in Mantle Cell Lymphoma

March 05, 2020

Article

An expert sheds light on the latest therapies in clinical trials and promising drug combinations to thwart the aggressive disease.

The Use of Immunotherapy in Blood Cancer Treatment

February 07, 2020

Video

Exciting Treatment Options Being Developed in Multiple Myeloma

February 07, 2020

Video

Genetic Sequencing in Chronic Lymphocytic Leukemia

February 07, 2020

Video

The Basics of Mantle Cell Lymphoma

February 07, 2020

Video

Joining a Clinical Trial

February 07, 2020

Video

The Basics of Stem Cell Transplantation

September 19, 2019

Article

Many patients with blood cancers may be candidates for autologous or allogeneic transplant.

Majority of 26,000 Calls to LLS Reflect Patient Financial Stress

May 16, 2017

Article